1. Home
  2. FOLD vs CAKE Comparison

FOLD vs CAKE Comparison

Compare FOLD & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • CAKE
  • Stock Information
  • Founded
  • FOLD 2002
  • CAKE 1972
  • Country
  • FOLD United States
  • CAKE United States
  • Employees
  • FOLD N/A
  • CAKE N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • CAKE Restaurants
  • Sector
  • FOLD Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • FOLD 2.5B
  • CAKE 2.7B
  • IPO Year
  • FOLD 2007
  • CAKE 1992
  • Fundamental
  • Price
  • FOLD $9.41
  • CAKE $46.28
  • Analyst Decision
  • FOLD Buy
  • CAKE Hold
  • Analyst Count
  • FOLD 7
  • CAKE 15
  • Target Price
  • FOLD $30.29
  • CAKE $57.87
  • AVG Volume (30 Days)
  • FOLD 5.0M
  • CAKE 1.6M
  • Earning Date
  • FOLD 11-04-2025
  • CAKE 10-28-2025
  • Dividend Yield
  • FOLD N/A
  • CAKE 2.35%
  • EPS Growth
  • FOLD N/A
  • CAKE 24.69
  • EPS
  • FOLD N/A
  • CAKE 3.29
  • Revenue
  • FOLD $598,704,000.00
  • CAKE $3,711,211,000.00
  • Revenue This Year
  • FOLD $21.12
  • CAKE $6.63
  • Revenue Next Year
  • FOLD $21.23
  • CAKE $4.95
  • P/E Ratio
  • FOLD N/A
  • CAKE $13.99
  • Revenue Growth
  • FOLD 21.28
  • CAKE 4.90
  • 52 Week Low
  • FOLD $5.51
  • CAKE $42.69
  • 52 Week High
  • FOLD $10.83
  • CAKE $69.70
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 67.64
  • CAKE 28.19
  • Support Level
  • FOLD $8.69
  • CAKE $45.53
  • Resistance Level
  • FOLD $9.64
  • CAKE $48.86
  • Average True Range (ATR)
  • FOLD 0.38
  • CAKE 1.73
  • MACD
  • FOLD 0.03
  • CAKE -0.48
  • Stochastic Oscillator
  • FOLD 82.68
  • CAKE 4.32

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: